ArticlePLOS global public health2022
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.
Sedona Sweeney et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this paperpooled itcites it